GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Long-Term Debt

Honz Pharmaceutical Co (SZSE:300086) Long-Term Debt : ¥246.1 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co Long-Term Debt?

Honz Pharmaceutical Co's Long-Term Debt for the quarter that ended in Sep. 2024 was ¥246.1 Mil.

Honz Pharmaceutical Co's quarterly Long-Term Debt declined from Mar. 2024 (¥322.0 Mil) to Jun. 2024 (¥267.1 Mil) and declined from Jun. 2024 (¥267.1 Mil) to Sep. 2024 (¥246.1 Mil).

Honz Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (¥343.5 Mil) to Dec. 2022 (¥342.8 Mil) and declined from Dec. 2022 (¥342.8 Mil) to Dec. 2023 (¥325.0 Mil).

Honz Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Honz Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honz Pharmaceutical Co Long-Term Debt Chart

Honz Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.23 324.50 343.52 342.85 324.98

Honz Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 305.14 324.98 322.05 267.06 246.06

Honz Pharmaceutical Co  (SZSE:300086) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Honz Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Honz Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Honz Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Long-Term Debt
Comparable Companies
SZSE:002370 SHSE:600080 SHSE:600513 SZSE:002365 SZSE:002817 SZSE:300519 SZSE:002693 SZSE:301331 BJSE:830946 SZSE:300254 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095
Website
http://www.honz.com.cn
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Executives
Wang Chun Ying Supervisors
Rui Shou Hong Director
Hong Jiang You Directors, executives
Hong Zhi Hui Director
He Zi Qun Supervisors
Hong Li Ping Directors, executives
Hong Jiang Tao Director
Liu Hui Liang Executives
Hu Fei Hong Director
Li Ping Independent director
Fu Lin Jun Director

Honz Pharmaceutical Co Headlines

No Headlines